MPT: Newer HeartMate LVAD Better for Longer-Term Use

ACC Conference Reporter

ACC.18 | ORLANDO, FL — The HeartMate 3 advantage appears durable to 2 years, with still no pump thrombosis requiring reoperation and fewer replacements or disabling strokes compared with the prior-generation device, the MOMENTUM 3 trial showed. Read More >>>



Keywords: ACC18, ACC Annual Scientific Session


< Back to Listings